Search results
Results from the WOW.Com Content Network
Sterne was the first to try metformin on humans for the treatment of diabetes; he coined the name "Glucophage" (glucose eater) for the medication and published his results in 1957. [161] [168] Metformin became available in the British National Formulary in 1958. It was sold in the UK by a small Aron subsidiary called Rona. [169]
Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names Glucophage, Fortamet, Riomet, and Glumetza.
Qternmet XR, Qtrilmet ... sold under the brand name Qternmet XR among others, is a fixed-dose combination anti-diabetic medication ... Text is available under the ...
To lessen the risk of developing ketoacidosis (a serious condition in which the body produces high levels of blood acids called ketones) after surgery, the FDA has approved changes to the prescribing information for SGLT2 inhibitor diabetes medicines to recommend they be stopped temporarily before scheduled surgery.
Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage). [1]
Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment
in adults inadequately controlled on their maximally tolerated dose of metformin alone; [6] in adults inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin; [6] in adults already being treated with the combination of empagliflozin and metformin as separate tablets. [6]
It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet XR). [8] Common side effects include headaches, swelling of the legs, and upper respiratory tract infections. [8] Serious side effects may include angioedema, low blood sugar, kidney problems, pancreatitis, and joint pain. [8]